Takeda Wants New Look at Patent in Hemophilia Rx Case Bloomberg Law
Takeda wants an appeals court to take another look at whether Genentech Inc.’s hemophilia drug Hemlibra infringes an antibody patent.
Takeda Wants New Look at Patent in Hemophilia Rx Case Bloomberg Law
Takeda wants an appeals court to take another look at whether Genentech Inc.’s hemophilia drug Hemlibra infringes an antibody patent.